On Invalid Date, Belite Bio (NASDAQ: BLTE) reported Q4 2022 earnings per share (EPS) of N/A, up N/A year over year. Total Belite Bio earnings for the quarter were N/A. In the same quarter last year, Belite Bio's earnings per share (EPS) was N/A.
As of Q2 2023, Belite Bio's earnings has grown year over year. Belite Bio's earnings in the past year totalled -$12.65 million.
What is BLTE's earnings date?
Belite Bio's earnings date is Invalid Date. Add BLTE to your watchlist to be reminded of BLTE's next earnings announcement.
What was BLTE's revenue last quarter?
On Invalid Date, Belite Bio (NASDAQ: BLTE) reported Q4 2022 revenue of N/A up N/A year over year. In the same quarter last year, Belite Bio's revenue was N/A.
What was BLTE's revenue growth in the past year?
As of Q2 2023, Belite Bio's revenue has grown null year over year. Belite Bio's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.